Prevalence of clinically significant incidental findings by whole-body FDG-PET/CT scanning in moderate-to-severe psoriasis patients participating in clinical trials

The prevalence of serious medical problems not detected by routine history, physical, and laboratory studies in patients with moderate-to-severe psoriasis presenting for clinical trials is not known. About 12% of patients had clinically significant incidental findings on FDG-PET/CT imaging, and 2.31% of patients had cancer.

http://bit.ly/2DaF983